CIK 0001737287 · Non-accelerated filer<br>Smaller reporting company
Allogene Therapeutics, Inc.
Sign in to watch- Ticker
- ALLO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 823562771
- Phone
- (650) 457-2700
- Business address
- 210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $111,656
- in 2 filings
Net −$111,656. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 47 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-05 | Mayo Stephen Director | Grant or award · Stock Option (Right to buy) | +191,082 | 191,082 | ||
| 2024-06-05 | Barrett Elizabeth A. Director | Grant or award · Stock Option (Right to buy) | +191,082 | 191,082 | ||
| 2024-06-05 | SATO VICKI L Director | Grant or award | +61,475 | 162,575 | ||
| 2024-06-05 | SATO VICKI L Director | Grant or award · Stock Option (Right to buy) | +95,541 | 95,541 | ||
| 2024-06-05 | Humer Franz B Director | Grant or award | +61,475 | 316,728 | ||
| 2024-06-05 | Humer Franz B Director | Grant or award · Stock Option (Right to buy) | +95,541 | 95,541 | ||
| 2024-06-05 | WITTE OWEN N. Director | Grant or award · Stock Option (Right to buy) | +191,082 | 191,082 | ||
| 2024-06-05 | Kazam Joshua A Director | Grant or award · Stock Option (Right to buy) | +191,082 | 191,082 | ||
| 2024-06-05 | MESSEMER DEBORAH M. Director | Grant or award | +122,950 | 185,406 | ||
| 2024-05-30 | Humer Franz B Director | Sale | −11,200 | $2.34 | $26K | 255,253 |
| 2024-05-16 | Belldegrun Arie Director | Grant or award | +344,828 | $2.90 | $1.0M | 539,867 |
| 2024-05-16 | Belldegrun Arie Director | Purchase | +1,724,137 | $2.90 | $5.0M | 1,724,137 |
| 2024-05-16 | Parker Geoffrey M. CHIEF FINANCIAL OFFICER | Grant or award | +344,828 | $2.90 | $1.0M | 1,164,418 |
| 2024-05-16 | Chang David D President and CEO | Grant or award | +344,828 | $2.90 | $1.0M | 4,810,106 |
| 2024-04-22 | MOORE TIMOTHY L. Chief Technical Officer | Shares withheld for taxes | −17,360 | $3.47 | $60K | 265,459 |
| 2024-03-14 | Chang David D President and CEO | Shares withheld for taxes | −53,393 | $4.33 | $231K | 4,465,278 |
| 2024-01-30 | Parker Geoffrey M. CHIEF FINANCIAL OFFICER | Purchase | +190 | $3.60 | $683 | 819,590 |
| 2024-01-25 | MOORE TIMOTHY L. Chief Technical Officer | Grant or award | +96,600 | 282,819 | ||
| 2024-01-25 | MOORE TIMOTHY L. Chief Technical Officer | Grant or award · Stock Option (Right to buy) | +341,515 | 341,515 | ||
| 2024-01-25 | Douglas Earl Martin SVP, General Counsel | Grant or award | +41,800 | 477,634 |
Page 5 of 18 · 348 trades